image 2 image 4
Skip Navigation Links
 Home 
 Congress Structure 
 Important Dates 
 Venue 
 Registration 
 Pre Registered 
 Hotel Info 
 Abstracts 
 Scientific Program 
 Social Program 
 Exhibition 
 Contact Us 
       XXV Annual Congress of the Iranian Society of Ophthalmology        بـیــست و پنجمین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
مقاله Abstract


Title: Clinical outcomes of MyoRing implantation versus combined corneal collagen cross-linking and MyoRing implantation in patients with keratoconus.
Author(s): 1 Sahar Mojaled Nobari, 1 Consuelo Villena, 2 Khosrow Jadidi
Presentation Type: Oral
Subject: Cornea and Anterior Segment
Others:
Presenting Author:
Name: Sahar Mojaled Nobari
Affiliation :(optional) PhD candidate of Optometry, Master in Optometry and Vision,Department of Optics II (Optometry and Vision), Complutense University, Avda Arcos de Jalón 118, Madrid, Spain
E mail: sahar_optica@hotmail.es
Phone: 44228239
Mobile: 09124949800
Purpose:

To compare combined MyoRing implantation with previously corneal collagen cross-linking (CXL- MyoRing) versus MyoRing implantation alone in patients with keratoconus.

Methods:

This retrospective comparative study included 33 eyes of 33 patients with keratoconus stage II and III according to Amsler-Krumeich classification. Two groups were performed for this study with 1 year follow up. The group 1 received MyoRing implantation and the group 2 received CXL approximately 11months before MyoRing implantation. All patients had a complete pre and post-operative examination including visual, refractive and keratometry examinations.

Results:

There was not observed a statistically significant difference between mean UDVA of two groups postoperatively (p = 0.142) whereas the mean CDVA in Group 2 was significantly better than mean Group 1(p = 0.018). SE and refractive astigmatism were significantly reduced in both groups.The mean keratometric values also were reduced in both groups at the end of follow up.

Conclusion:

Both combined CXL- MyoRing and MyoRing implantation alone were effective treatment for moderate and severe keratoconus and resulted in similar clinical outcomes after one year follow up.Overally MyoRing implantation alone demonstrated better outcome in mean CDVA.

Attachment:





Skip Navigation Links
        صفحه اصلی
        ساختار کنگره
        تاریخ های مهم
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
        اطلاعات هتل - رزرو
        مقالات
        برنامه کنگره
        جشنواره فیلم و عکس
        نمایشگاه
        تماس با ما
        جستجوی سخنران
 
Last News

  - بـیــست و پنجمین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران